As anticipated, the IFN-I score was increased in more than 80% of patients with anti-MDA5+ DM and was significantly higher in individuals with anti-MDA5+ DM than in patients with SLE, RA, AOSD, and SS. This evidence concerns the gene IFIH1 and systemic lupus erythematosus.